Specific Plant Foods Reduce Premature Aging in Childhood Cancer Survivors
29 Jan 2024
MONDAY, Jan. 29, 2024 -- For childhood cancer survivors, specific plant foods are associated with a lower risk for premature aging, according to a study published online Jan. 23 in the Journal of Clinical Oncology.
Mei Wang, from the Alvin J. Siteman Cancer Center at the Washington University School of Medicine in St. Louis, and colleagues examined the associations between plant food intakes and age-related deficit accumulation among 3,322 childhood cancer survivors. A food frequency questionnaire was used to assess total fruit, total vegetables and subgroups, whole grains, refined grains, nuts/seeds, and nutrients intake.
The researchers found that intakes of dark green vegetables and nuts/seeds were associated with a lower risk for premature aging. Conversely, an increased risk for premature aging was seen in relation to refined grain intake. No association was seen for fruit and whole grain intake with premature aging risk. Among nutrients abundant in plant foods, there was an association observed for dietary folate intake with a lower risk for premature aging. Beta-carotene, lutein/zeaxanthin, and vitamin E intakes from foods were associated with a modestly lower risk for premature aging, but the link was not statistically significant.
"Eating healthier plant foods at any life stage may have benefits that extend later into the lifespan by lowering risk of premature aging," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.